Vor Biopharma VOR EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vor Biopharma's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vor Biopharma's EPS (diluted)?
- Vor Biopharma (VOR) reported EPS (diluted) of -$5.11 in Q1 2026.
- How has Vor Biopharma's EPS (diluted) changed year-over-year?
- Vor Biopharma's EPS (diluted) increased by 1.9% year-over-year, from -$5.21 to -$5.11.
- What is the long-term trend for Vor Biopharma's EPS (diluted)?
- Over 3 years (2021 to 2024), Vor Biopharma's EPS (diluted) has grown at a 101.9% compound annual growth rate (CAGR), from -$2.15 to -$17.69.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.